The decrease in Wnt3a expression after inhibiting CCNG1 suggests that CCNG1 might function as a negative regulator to impede the Wnt signaling−mediated cell proliferation, thereby contributing to the decreased number of AT2 cells in the BPD model. This evidence concerns the gene WNT3A and bronchopulmonary dysplasia.